Centiva Capital, LP Artivion, Inc. Transaction History
Centiva Capital, LP
- $4.79 Billion
- Q3 2024
A detailed history of Centiva Capital, LP transactions in Artivion, Inc. stock. As of the latest transaction made, Centiva Capital, LP holds 21,237 shares of AORT stock, worth $657,497. This represents 0.01% of its overall portfolio holdings.
Number of Shares
21,237Holding current value
$657,497% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding AORT
# of Institutions
179Shares Held
36.1MCall Options Held
33KPut Options Held
900-
Black Rock Inc. New York, NY6.64MShares$205 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.8MShares$86.8 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY2.79MShares$86.5 Million1.94% of portfolio
-
Macquarie Group LTD Australia, C32.75MShares$85 Million0.08% of portfolio
-
Morgan Stanley New York, NY2.45MShares$75.9 Million0.0% of portfolio
About ARTIVION, INC.
- Ticker AORT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 40,316,100
- Market Cap $1.25B
- Description
- Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...